Machine learning methods to predict mechanical ventilation and mortality in patients with COVID-19.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 23 11 2020
accepted: 15 03 2021
entrez: 1 4 2021
pubmed: 2 4 2021
medline: 14 4 2021
Statut: epublish

Résumé

The Coronavirus disease 2019 (COVID-19) pandemic has affected millions of people across the globe. It is associated with a high mortality rate and has created a global crisis by straining medical resources worldwide. To develop and validate machine-learning models for prediction of mechanical ventilation (MV) for patients presenting to emergency room and for prediction of in-hospital mortality once a patient is admitted. Two cohorts were used for the two different aims. 1980 COVID-19 patients were enrolled for the aim of prediction ofMV. 1036 patients' data, including demographics, past smoking and drinking history, past medical history and vital signs at emergency room (ER), laboratory values, and treatments were collected for training and 674 patients were enrolled for validation using XGBoost algorithm. For the second aim to predict in-hospital mortality, 3491 hospitalized patients via ER were enrolled. CatBoost, a new gradient-boosting algorithm was applied for training and validation of the cohort. Older age, higher temperature, increased respiratory rate (RR) and a lower oxygen saturation (SpO2) from the first set of vital signs were associated with an increased risk of MV amongst the 1980 patients in the ER. The model had a high accuracy of 86.2% and a negative predictive value (NPV) of 87.8%. While, patients who required MV, had a higher RR, Body mass index (BMI) and longer length of stay in the hospital were the major features associated with in-hospital mortality. The second model had a high accuracy of 80% with NPV of 81.6%. Machine learning models using XGBoost and catBoost algorithms can predict need for mechanical ventilation and mortality with a very high accuracy in COVID-19 patients.

Sections du résumé

BACKGROUND
The Coronavirus disease 2019 (COVID-19) pandemic has affected millions of people across the globe. It is associated with a high mortality rate and has created a global crisis by straining medical resources worldwide.
OBJECTIVES
To develop and validate machine-learning models for prediction of mechanical ventilation (MV) for patients presenting to emergency room and for prediction of in-hospital mortality once a patient is admitted.
METHODS
Two cohorts were used for the two different aims. 1980 COVID-19 patients were enrolled for the aim of prediction ofMV. 1036 patients' data, including demographics, past smoking and drinking history, past medical history and vital signs at emergency room (ER), laboratory values, and treatments were collected for training and 674 patients were enrolled for validation using XGBoost algorithm. For the second aim to predict in-hospital mortality, 3491 hospitalized patients via ER were enrolled. CatBoost, a new gradient-boosting algorithm was applied for training and validation of the cohort.
RESULTS
Older age, higher temperature, increased respiratory rate (RR) and a lower oxygen saturation (SpO2) from the first set of vital signs were associated with an increased risk of MV amongst the 1980 patients in the ER. The model had a high accuracy of 86.2% and a negative predictive value (NPV) of 87.8%. While, patients who required MV, had a higher RR, Body mass index (BMI) and longer length of stay in the hospital were the major features associated with in-hospital mortality. The second model had a high accuracy of 80% with NPV of 81.6%.
CONCLUSION
Machine learning models using XGBoost and catBoost algorithms can predict need for mechanical ventilation and mortality with a very high accuracy in COVID-19 patients.

Identifiants

pubmed: 33793600
doi: 10.1371/journal.pone.0249285
pii: PONE-D-20-36839
pmc: PMC8016242
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0249285

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Gen Intern Med. 2020 Aug;35(8):2516-2517
pubmed: 32519326
J Crit Care. 2021 Apr;62:25-30
pubmed: 33238219
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet Infect Dis. 2020 Jul;20(7):773
pubmed: 32171390
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
PLoS One. 2020 Mar 3;15(3):e0229331
pubmed: 32126097
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
J Clin Med. 2020 Jun 01;9(6):
pubmed: 32492874
Eur Respir J. 2020 Aug 20;56(2):
pubmed: 32616597
Am J Trop Med Hyg. 2020 Aug;103(2):605-608
pubmed: 32597389
medRxiv. 2020 May 22;:
pubmed: 32511520
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Infect Dis. 2020 Jul 28;71(15):769-777
pubmed: 32176772
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003

Auteurs

Limin Yu (L)

Department of Pathology, Beaumont Health System, Royal Oak, MI, United States of America.

Alexandra Halalau (A)

Department of Internal Medicine, Beaumont Health System, Royal Oak, MI, United States of America.

Bhavinkumar Dalal (B)

Division of Pulmonary and Critical Care Medicine, Beaumont Health System, Royal Oak, MI, United States of America.

Amr E Abbas (AE)

Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, United States of America.

Felicia Ivascu (F)

Department of General Surgery, Beaumont Health System, Royal Oak, MI, United States of America.

Mitual Amin (M)

Department of Pathology, Beaumont Health System, Royal Oak, MI, United States of America.

Girish B Nair (GB)

Division of Pulmonary and Critical Care Medicine, Beaumont Health System, Royal Oak, MI, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH